Pluristem Therapeutics intends to conduct a U.S./EU Phase III trial assessing use of PLX-PAD (PLacental eXpanded) cells to support recovery following surgery for femoral neck fracture.
The study design builds upon positive data from the Phase II trial which showed that PLX-PAD cells induced significant muscle regeneration following total hip replacement. Compared to placebo, patients treated with PLX-PAD at the time of surgery showed a 500% improvement in muscle force and a 300% improvement in muscle volume at 6 months.
Earlier results from the Phase I/II study were announced in 1Q15.
Sources: Plurstem Therapeutics, Inc.; ORTHOWORLD Inc.
Pluristem Therapeutics intends to conduct a U.S./EU Phase III trial assessing use of PLX-PAD (PLacental eXpanded) cells to support recovery following surgery for femoral neck fracture.
The study design builds upon positive data from the Phase II trial which showed that PLX-PAD cells induced significant muscle regeneration following total...
Pluristem Therapeutics intends to conduct a U.S./EU Phase III trial assessing use of PLX-PAD (PLacental eXpanded) cells to support recovery following surgery for femoral neck fracture.
The study design builds upon positive data from the Phase II trial which showed that PLX-PAD cells induced significant muscle regeneration following total hip replacement. Compared to placebo, patients treated with PLX-PAD at the time of surgery showed a 500% improvement in muscle force and a 300% improvement in muscle volume at 6 months.
Earlier results from the Phase I/II study were announced in 1Q15.
Sources: Plurstem Therapeutics, Inc.; ORTHOWORLD Inc.
You are out of free articles for this month
Subscribe as a Guest for $0 and unlock a total of 5 articles per month.
You are out of five articles for this month
Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.
JV
Julie Vetalice is ORTHOWORLD's Editorial Assistant. She has covered the orthopedic industry for over 20 years, having joined the company in 1999.